nteresting post from the YMB.
drD is a well regarded
nteresting post from the YMB.
drD is a well regarded poster and accomplished surgeon whose family has had first hand experience with Leronlimab when one of her family members got severely ill awhile back. I would regard her posts as highly credible so this is encouraging news.
Noobie
drD
drD2 hours ago
For those of you who are not aware , there are many sites on the internet that are private and restricted to doctors only ( MD and PhDs ) . They are not anonymous as our names and locations are clearly displayed . The purpose is for open discourse between doctors without the interference of those who have a conflict of interest with our opinions such as BP . Many side effects and pros and cons of medications are discussed on these boards .
Today these boards ( I’ve checked 6 so far ) are ABLAZE!!!! With News of LERONLIMAB!!!!
The grapevine is on FIRE
22
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...
Continue Reading
Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...
Continue Reading
Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...
Continue Reading
We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...
Continue Reading
An Unexpected Turn in the UBI Movement In a world where tech and economic security must dance together, minding the steps is crucial. And this time, Amy Wilson's got her dancing shoes on. On September 24, 2026, the Income To Support All (ITSA) Foundation made some waves by adding Wilson to its board of directors, a move showing they're more serious than ever about...
Continue Reading
What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...
Continue Reading
Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...
Continue Reading
When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...
Continue Reading
PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...
Continue Reading
AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting New Model Homes by Richmond American Four new model homes are now open for tours at Seasons at Riverton Richmond American Homes, a recognized subsidiary of M.D.C. Holdings, Inc., has unveiled four stunning model homes at the Seasons at Riverton community. This development stands out for prospective homebuyers looking for quality residences that blend comfort with...
Continue Reading
Bladex's Strong Performance Metrics for 2Q25 Banco Latinoamericano de Comercio Exterior, S.A. (NYSE: BLX), commonly known as Bladex, has released its financial results for the second quarter of the fiscal year. The bank showcases an impressive net profit of $64.2 million, equating to earnings per share of $1.73, which reflects an annualized return on equity (ROE) of...
Continue Reading
Class Action Alert for Cepton, Inc. Investors In recent news, a class action lawsuit has emerged targeting Cepton, Inc. (NASDAQ: CPTN). This lawsuit is critical for investors who may have suffered losses during a defined period. Legal representatives are reaching out to these investors, urging them to take action. Understanding the Lawsuit The class action was initiated...
Continue Reading
RA Capital and OMERS Team Up for ARS Pharma's Future RA Capital Management, LP together with OMERS Life Sciences, has announced a significant financing initiative aimed at bolstering ARS Pharmaceuticals, Inc. This multi-faceted loan facility is poised to inject $250 million into the innovative biopharma company, with an initial allocation of $100 million earmarked for...
Continue Reading
Team Connections Bring Joy to Hospitality Professionals A recent OysterLink poll has shed light on the factors that contribute to happiness in the hospitality sector. Significantly, 56% of hospitality workers indicated that their joy at work primarily stems from fostering strong connections with their colleagues. The Power of Teamwork The survey engaged over 100...
Continue Reading